Ferrer Ciro, Cao Piergiorgio
Unit of Vascular Surgery, Department of Surgery "Pietro Valdoni", Sapienza University of Rome, Rome, Italy.
Mater Dei Hospital, Rome, Italy.
Ann Cardiothorac Surg. 2018 May;7(3):366-371. doi: 10.21037/acs.2018.04.08.
In the light of current evidence, endovascular repair of aortic arch pathologies with custom-made devices should be considered a valid alternative to decrease operative mortality and morbidity associated with open or hybrid repair. Currently, two double inner branch devices are available on the market. Some papers from multicenter experiences have been published about the use of Cook device. We report our single-center experience with Bolton double branch stent graft in the treatment of aortic arch disease.
Between 2013 and 2016, nine high-risk patients with arch pathology were treated in our center with a Bolton custom-made branched device. Among these, two with a single branch model were excluded, leaving a subgroup of seven patients of this study.
Out of the seven male patients (mean age, 76; range, 70-85) included in the study, two (28%) died perioperatively after stroke (14%) and retrograde dissection (14%), respectively. No other death, major complications, including aneurysmal diameter evolution and branch related complications, or secondary intervention was recorded at a mean follow up of 24 [6-53] months.
Despite the small sample size, our results are in line with the early experiences published on this technique. Endovascular repair of aortic arch disease with custom-made branched devices should always be considered to give high-risk patients a chance of repair.
根据目前的证据,使用定制装置对主动脉弓病变进行血管腔内修复应被视为降低与开放或杂交修复相关的手术死亡率和发病率的有效替代方法。目前,市场上有两种双内分支装置。已经发表了一些关于使用库克装置的多中心经验的论文。我们报告了我们使用博尔顿双分支支架移植物治疗主动脉弓疾病的单中心经验。
2013年至2016年期间,我们中心使用博尔顿定制分支装置治疗了9例患有弓部病变的高危患者。其中,排除了2例使用单分支模型的患者,本研究留下了7例患者的亚组。
在纳入研究的7例男性患者(平均年龄76岁;范围70 - 85岁)中,2例(28%)分别在围手术期因中风(14%)和逆行夹层(14%)死亡。在平均24 [6 - 53]个月的随访中,未记录到其他死亡、主要并发症,包括动脉瘤直径演变和分支相关并发症,或二次干预。
尽管样本量较小,但我们的结果与关于该技术的早期经验一致。对于高危患者,应始终考虑使用定制分支装置对主动脉弓疾病进行血管腔内修复,以给予他们修复的机会。